Praxis Precision Medicines, Inc. - Common Stock (PRAX)
CUSIP: 74006W207
Q3 2024 13F Holders as of 30 Sep 2024
- Type / Class
- Equity / Common Stock
- Shares outstanding
- 27,884,538
- Total 13F shares
- 18,868,572
- Share change
- +427,761
- Total reported value
- $1,091,231,093
- Put/Call ratio
- 81%
- Price per share
- $57.54
- Number of holders
- 132
- Value change
- +$44,014,289
- Number of buys
- 71
- Number of sells
- 58
Quarterly Holders Quick Answers
What is CUSIP 74006W207?
CUSIP 74006W207 identifies PRAX - Praxis Precision Medicines, Inc. - Common Stock in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 74006W207:
Top shareholders of PRAX - Praxis Precision Medicines, Inc. - Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| Clarus Lifesciences III, L.P. |
3/4/5
|
10%+ Owner |
—
class O/S missing
|
4,894,109
|
$123,282,606 | — | 12 May 2021 | |
| BlackRock Finance, Inc. |
13F
|
Company |
4.6%
|
1,294,000
|
$53,519,840 | — | 30 Jun 2024 | |
| RA CAPITAL MANAGEMENT, L.P. |
13F
|
Company |
4.4%
|
1,235,599
|
$51,104,375 | — | 30 Jun 2024 | |
| ADAGE CAPITAL PARTNERS GP, L.L.C. |
13F
|
Company |
4.1%
|
1,134,083
|
$46,905,673 | — | 30 Jun 2024 | |
| Point72 Asset Management, L.P. |
13F
|
Company |
3.8%
|
1,051,701
|
$43,498,353 | — | 30 Jun 2024 | |
| VANGUARD GROUP INC |
13F
|
Company |
3.5%
|
977,145
|
$40,414,717 | — | 30 Jun 2024 | |
| PRICE T ROWE ASSOCIATES INC /MD/ |
13F
|
Company |
3.4%
|
938,579
|
$38,820,000 | — | 30 Jun 2024 | |
| STATE STREET CORP |
13F
|
Company |
2.9%
|
819,142
|
$33,879,713 | — | 30 Jun 2024 | |
| PERCEPTIVE ADVISORS LLC |
13F
|
Company |
2.7%
|
750,230
|
$31,029,513 | — | 30 Jun 2024 | |
| Verition Fund Management LLC |
13F
|
Company |
2.7%
|
748,320
|
$30,950,515 | — | 30 Jun 2024 | |
| VR Adviser, LLC |
13F
|
Company |
2.5%
|
706,131
|
$29,205,578 | — | 30 Jun 2024 | |
| Cormorant Asset Management, LP |
13F
|
Company |
2.5%
|
685,000
|
$28,331,600 | — | 30 Jun 2024 | |
| Soleus Capital Management, L.P. |
13F
|
Company |
1.9%
|
533,015
|
$22,045,500 | — | 30 Jun 2024 | |
| PFM Health Sciences, LP |
13F
|
Company |
1.6%
|
453,146
|
$18,742,119 | — | 30 Jun 2024 | |
| Vestal Point Capital, LP |
13F
|
Company |
1.6%
|
440,000
|
$18,198,400 | — | 30 Jun 2024 | |
| KINGDON CAPITAL MANAGEMENT, L.L.C. |
13F
|
Company |
1.5%
|
415,000
|
$17,164,400 | — | 30 Jun 2024 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
1.4%
|
395,059
|
$16,342,988 | — | 30 Jun 2024 | |
| Deep Track Capital, LP |
13F
|
Company |
1.4%
|
389,546
|
$16,111,623 | — | 30 Jun 2024 | |
| JANUS HENDERSON GROUP PLC |
13F
|
Company |
1.4%
|
381,685
|
$15,862,829 | — | 30 Jun 2024 | |
| Velan Capital Investment Management LP |
13F
|
Company |
1.3%
|
350,666
|
$14,503,546 | — | 30 Jun 2024 | |
| 5AM Venture Management, LLC |
13F
|
Company |
1.2%
|
340,000
|
$14,062,400 | — | 30 Jun 2024 | |
| FMR LLC |
13F
|
Company |
1%
|
290,979
|
$12,034,892 | — | 30 Jun 2024 | |
| SPHERA FUNDS MANAGEMENT LTD. |
13F
|
Company |
1%
|
283,424
|
$11,722,417 | — | 30 Jun 2024 | |
| DRIEHAUS CAPITAL MANAGEMENT LLC |
13F
|
Company |
0.95%
|
264,688
|
$10,947,496 | — | 30 Jun 2024 | |
| Octagon Capital Advisors LP |
13F
|
Company |
0.93%
|
260,000
|
$10,753,600 | — | 30 Jun 2024 | |
| MARSHALL WACE, LLP |
13F
|
Company |
0.89%
|
248,381
|
$10,273,038 | — | 30 Jun 2024 | |
| FRANKLIN RESOURCES INC |
13F
|
Company |
0.86%
|
239,898
|
$9,922,181 | — | 30 Jun 2024 | |
| CIBC Asset Management Inc |
13F
|
Company |
0.69%
|
192,667
|
$7,968,707 | — | 30 Jun 2024 | |
| MORGAN STANLEY |
13F
|
Company |
0.66%
|
184,319
|
$7,623,434 | — | 30 Jun 2024 | |
| Nuveen Asset Management, LLC |
13F
|
Company |
0.63%
|
174,667
|
$7,224,226 | — | 30 Jun 2024 | |
| ACUTA CAPITAL PARTNERS, LLC |
13F
|
Company |
0.59%
|
164,431
|
$6,800,866 | — | 30 Jun 2024 | |
| Ally Bridge Group (NY) LLC |
13F
|
Company |
0.55%
|
153,379
|
$6,343,755 | — | 30 Jun 2024 | |
| BAKER BROS. ADVISORS LP |
13F
|
Company |
0.47%
|
131,533
|
$5,440,205 | — | 30 Jun 2024 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0.47%
|
130,997
|
$5,418,036 | — | 30 Jun 2024 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
0.33%
|
90,909
|
$3,759,996 | — | 30 Jun 2024 | |
| Qube Research & Technologies Ltd |
13F
|
Company |
0.33%
|
90,693
|
$3,751,063 | — | 30 Jun 2024 | |
| RENAISSANCE TECHNOLOGIES LLC |
13F
|
Company |
0.27%
|
75,433
|
$3,119,909 | — | 30 Jun 2024 | |
| Tri Locum Partners LP |
13F
|
Company |
0.27%
|
75,319
|
$3,115,194 | — | 30 Jun 2024 | |
| SILVERARC CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.24%
|
67,296
|
$2,783,363 | — | 30 Jun 2024 | |
| 72 Investment Holdings, LLC |
13F
|
Company |
0.24%
|
65,933
|
$2,726,989 | — | 30 Jun 2024 | |
| JACOBS LEVY EQUITY MANAGEMENT, INC |
13F
|
Company |
0.23%
|
63,361
|
$2,620,611 | — | 30 Jun 2024 | |
| WELLINGTON MANAGEMENT GROUP LLP |
13F
|
Company |
0.18%
|
51,513
|
$2,130,578 | — | 30 Jun 2024 | |
| TD ASSET MANAGEMENT INC |
13F
|
Company |
0.18%
|
51,312
|
$2,122,264 | — | 30 Jun 2024 | |
| Bank of New York Mellon Corp |
13F
|
Company |
0.18%
|
49,510
|
$2,047,734 | — | 30 Jun 2024 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.17%
|
48,069
|
$1,988,134 | — | 30 Jun 2024 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.17%
|
47,474
|
$1,963,525 | — | 30 Jun 2024 | |
| Rafferty Asset Management, LLC |
13F
|
Company |
0.15%
|
41,358
|
$1,710,567 | — | 30 Jun 2024 | |
| Ovata Capital Management Ltd |
13F
|
Company |
0.14%
|
40,000
|
$1,654,400 | — | 30 Jun 2024 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0.14%
|
38,554
|
$1,594,594 | — | 30 Jun 2024 | |
| OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) |
13F
|
Company |
0.13%
|
35,729
|
$1,477,751 | — | 30 Jun 2024 |
Institutional Holders of Praxis Precision Medicines, Inc. - Common Stock (PRAX) as of Q3 2024
As of 30 Sep 2024,
Praxis Precision Medicines, Inc. - Common Stock (PRAX) was held by
132 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
18,868,572 shares.
The largest 10 holders included
BlackRock, Inc., PERCEPTIVE ADVISORS LLC, PRICE T ROWE ASSOCIATES INC /MD/, VANGUARD GROUP INC, Point72 Asset Management, L.P., Capital Research Global Investors, Cormorant Asset Management, LP, ADAGE CAPITAL PARTNERS GP, L.L.C., STATE STREET CORP, and RA CAPITAL MANAGEMENT, L.P..
This page lists
132
institutional shareholders reporting positions in this security
for the Q3 2024 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q3 2024 vs Q2 2024 Across Filers
Q2 2024 holders
113
Q3 2024 holders
132
Holder diff
19
| Investor | Q2 2024 Shares | Q3 2024 Shares | Share Diff | Share Chg % | Q2 2024 Value $ | Q3 2024 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.